OrbiMed’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $263M | Hold |
|
|||||
|
2025
Q1 | $279M | Hold |
|
|||||
|
2024
Q4 | $261M | Hold |
|
|||||
|
2024
Q3 | $299M | Hold |
|
|||||
|
2024
Q2 | $306M | Sell |
|
|||||
|
2024
Q1 | $281M | Sell |
|
|||||
|
2023
Q4 | $213M | Buy |
|
|||||
|
2023
Q3 | $99.9M | Hold |
|
|||||
|
2023
Q2 | $87.2M | Hold |
|
|||||
|
2023
Q1 | $63.9M | Buy |
|
|||||
|
2022
Q4 | – | Hold |
|
|||||
|
2022
Q3 | – | Hold |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $193M | Sell |
|
|||||
|
2017
Q3 | $263M | Hold |
|
|||||
|
2017
Q2 | $253M | Sell |
|
|||||
|
2017
Q1 | $280M | Buy |
|
|||||
|
2016
Q4 | $201M | Buy |
|
|||||
|
2016
Q3 | $164M | Buy |
|
|||||
|
2016
Q2 | $116M | Sell |
|
|||||
|
2016
Q1 | $183M | Buy |
|
|||||
|
2015
Q4 | $136M | Buy |
|
|||||
|
2015
Q3 | $106M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $7.26M | Sell |
|
|||||
|
2014
Q2 | $24.9M | Sell |
|
|||||
|
2014
Q1 | $32M | Buy |
|
|||||
|
2013
Q3 | – | Hold |
|
|||||
|
2013
Q2 | – | Hold |
|